Lexaria Bioscience Warrant
LEXXW
LEXXW was delisted on the 13th of January, 2026.
3 hedge funds and large institutions have $63.9K invested in Lexaria Bioscience Warrant in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
41% less capital invested
Capital invested by funds: $109K → $63.9K (-$45.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$115 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$75.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Heights Capital Management
San Francisco,
California
| $37.9K | +$47.5K | +41,251 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $25.8K | -$75.6K | -65,657 | -70% |
|
|
CS
3
Clear Street
New York
| $184 | +$115 | +100 | +100% |
|
LEXXW Hedge Fund Activity: Q3 2024 in Review
3 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q3 2024, worth a combined $63.9K — down 41% from $109K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LEXXW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, adding an estimated $115. The largest seller was UBS Group, cutting an estimated $75.6K.
- 3 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $63.9K of Lexaria Bioscience Warrant stock for Q3 2024, down 41% quarter-over-quarter.
- 1 fund opened new Lexaria Bioscience Warrant positions in Q3 2024 and 0 closed out, a net change of +1 holder.
- The largest Lexaria Bioscience Warrant buyer in Q3 2024 was Clear Street, an estimated $115 added.
- The largest Lexaria Bioscience Warrant seller in Q3 2024 was UBS Group, an estimated $75.6K sold.
Based on aggregated 13F filings for Q3 2024.